<?xml version="1.0" encoding="UTF-8"?>
<ref id="B134-pharmaceuticals-12-00157">
 <label>134.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kanno</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kobuchi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kajitani</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Utsumi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Yano</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Horton</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Yasuda</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Utsumi</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells</article-title>
  <source>Physiol. Chem. Phys. Med. NMR</source>
  <year>2002</year>
  <volume>34</volume>
  <fpage>1</fpage>
  <lpage>15</lpage>
  <pub-id pub-id-type="pmid">12403272</pub-id>
 </element-citation>
</ref>
